Detalhe da pesquisa
1.
Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B.
J Hepatol
; 74(2): 283-292, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931877
2.
Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a.
Liver Int
; 40(2): 324-332, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721419
3.
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.
J Viral Hepat
; 26(9): 1040-1049, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972912
4.
Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study.
Hepatology
; 68(5): 1681-1694, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689122
5.
Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B.
J Infect Dis
; 218(7): 1066-1074, 2018 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741634
6.
Durability of Response in Children Treated With Pegylated Interferon alfa [corrected] 2a ± Ribavirin for Chronic Hepatitis C.
J Pediatr Gastroenterol Nutr
; 62(1): 93-6, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284539
7.
Long-term growth outcomes in children treated for chronic hepatitis C.
J Pediatr
; 165(6): 1252-4, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25241178
8.
Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.
Antivir Ther
; 24(2): 133-140, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865588